Last edition
News about "Pharmaceutical licensing"
Sentynl and Mereo Partner on Alvelestat for AATD-Associated Lung Disease
Sentynl Therapeutics and Mereo BioPharma have signed an option and license deal for alvelestat, with Sentynl set to commercialise it in the US upon option exercise.
Pharmaceutical Licensing | 12/08/2026 | By News Bureau
Kaigene Licenses Autoimmune Drug KG006 to Taisho Pharma in Japan
Taisho Pharmaceutical secures exclusive rights to clinically develop, register, and commercialise Kaigene's next-generation FcRn inhibitor, KG006, in Japan.
Pharmaceutical Licensing | 01/08/2026 | By News Bureau | 133
ICMR Transfers 3 Indigenous Biomedical Technologies
ICMR has transferred 3 indigenous biomedical technologies, including an anti-HPV candidate and enteric vaccines, to accelerate cancer and infectious disease solutions.
Pharmaceutical Licensing | 23/07/2026 | By News Bureau | 114
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy